Literature DB >> 14575821

Hypofractionation for prostate cancer radiotherapy--what are the issues?

David J Brenner.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14575821     DOI： 10.1016/s0360-3016(03)01456-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  19 in total

1.  Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy.

Authors:  M Geier; S T Astner; M N Duma; V Jacob; C Nieder; J Putzhammer; C Winkler; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-02-26       Impact factor: 3.621

2.  Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.

Authors:  Trinitat García Hernández; Aurora Vicedo González; Jorge Pastor Peidro; Juan V Roselló Ferrando; Luis Brualla González; Domingo Granero Cabañero; José López Torrecilla
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-08

3.  Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.

Authors:  Cécile Proust-Lima; Jeremy M G Taylor; Solène Sécher; Howard Sandler; Larry Kestin; Tom Pickles; Kyoungwha Bae; Roger Allison; Scott Williams
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

4.  Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicity.

Authors:  F Alongi; A Fogliata; P Navarria; A Tozzi; P Mancosu; F Lobefalo; G Reggiori; A Clivio; L Cozzi; M Scorsetti
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

5.  Tracing the earliest medical uses of high dose-per-fraction external beam radiation.

Authors:  Brian D Kavanagh
Journal:  J Radiosurg SBRT       Date:  2011

6.  Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Authors:  Susan L Tucker; Howard D Thames; Jeff M Michalski; Walter R Bosch; Radhe Mohan; Kathryn Winter; James D Cox; James A Purdy; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

7.  On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Authors:  Z Jay Chen; Jun Deng; Kenneth Roberts; Ravinder Nath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-05       Impact factor: 7.038

Review 8.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

9.  Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.

Authors:  Simona Marzi; Biancamaria Saracino; Maria G Petrongari; Stefano Arcangeli; Sara Gomellini; Giorgio Arcangeli; Marcello Benassi; Valeria Landoni
Journal:  J Exp Clin Cancer Res       Date:  2009-08-19

10.  Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.

Authors:  Paola Pinnarò; Antonella Soriani; Valeria Landoni; Carolina Giordano; Maria Papale; Annelisa Marsella; Laura Marucci; Giorgio Arcangeli; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2010-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.